HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer.
Hosonaga M, Arima Y, Sampetrean O, Komura D, Koya I, Sasaki T, Sato E, Okano H, Kudoh J, Ishikawa S, Saya H, Ishikawa T.
Hosonaga M, et al. Among authors: sato e.
Int J Mol Sci. 2018 Jul 24;19(8):2158. doi: 10.3390/ijms19082158.
Int J Mol Sci. 2018.
PMID: 30042341
Free PMC article.